Search - tctmd.com

Displaying 441 - 460 of 550

Sort: Relevancy | Date

News Daily News

Los Datos del Registro PARTNER Documentan los Avances en TAVR Transfemorales

L.A. McKeown

December 04, 2014

News Daily News

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Caitlin E. Cox

November 19, 2014

News Daily News

A Changing Job Market for Fellows Requires New Perspective, Resources From Trainers

Yael L. Maxwell

November 11, 2014

News Opinion Fellow Talk

Addressing the Gender Gap

Siddharth A. Wayangankar, MD, MPH

November 05, 2014

News Daily News

Invasive Measurements Confirm Quick Recovery of Microcirculation After Primary PCI

November 02, 2014

News Daily News

Mediciones Invasivas Confirman una Rápida Recuperación de la Microcirculación Post-PCI Primaria

November 02, 2014

News Daily News

Cardiologists ‘Wary’ of Inadequate EHR Systems

October 24, 2014

News Daily News

La FA Preexistente, No de Reciente Aparición, Predice Peores Resultados a Largo Plazo Post-TAVR

October 17, 2014

News Daily News

La Trombocitopenia Preexistente Empeora las Complicaciones Post-TAVR

L.A. McKeown

October 16, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Industry News

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

September 13, 2014

News Conference News ESC 2014

MITOCARE: Novel Drug as Adjunct to PCI for STEMI Does Not Reduce Reperfusion Injury Risk

Yael L. Maxwell

September 02, 2014

News Daily News

EVAR Results in Higher Patient-Level Safety Benefit than Surgery for AAA

L.A. McKeown

July 17, 2014

News Daily News

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

L.A. McKeown

July 03, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

News Industry News

Thoratec Acquires Apica Cardiovascular

July 02, 2014

News Daily News

Bleeding Rates Decrease When Hospitals Up Use of Radial PCI

L.A. McKeown

June 09, 2014

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Daily News

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

May 30, 2014

Advertisement

Los Datos del Registro PARTNER Documentan los Avances en TAVR Transfemorales

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

A Changing Job Market for Fellows Requires New Perspective, Resources From Trainers

Addressing the Gender Gap

Invasive Measurements Confirm Quick Recovery of Microcirculation After Primary PCI

Mediciones Invasivas Confirman una Rápida Recuperación de la Microcirculación Post-PCI Primaria

Cardiologists ‘Wary’ of Inadequate EHR Systems

La FA Preexistente, No de Reciente Aparición, Predice Peores Resultados a Largo Plazo Post-TAVR

La Trombocitopenia Preexistente Empeora las Complicaciones Post-TAVR

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

MITOCARE: Novel Drug as Adjunct to PCI for STEMI Does Not Reduce Reperfusion Injury Risk

EVAR Results in Higher Patient-Level Safety Benefit than Surgery for AAA

Strategy of Potent Anticoagulation with Rapid Post-PCI Reversal Appears Safe, Effective

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

Thoratec Acquires Apica Cardiovascular

Bleeding Rates Decrease When Hospitals Up Use of Radial PCI

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

Primer Estudio en Humanos ILLUMENATE: Un Nuevo Balón Recubierto de Fármacos Arroja Resultados Sólidos a los 2 Años en Lesiones de la Arteria Femoral Superficial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content